Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Asha Iyer

Neurological Surgery Sacramento, CA Medical Doctor

NPI 1831410299 CMS profile 2788748

2800 L St Ste 501, Sacramento, CA 95816

Open in the dashboard

General payments

$8,419

114 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Asha Iyer of Sacramento, CA is reported in the CMS Open Payments database as having received $8,419 across 114 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 67th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $273 5
2024 General $5,418 52
2023 General $334 9
2022 General $546 14
2021 General $391 10
2020 General $1,125 17
2019 General $331 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Asha Iyer
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Asha Iyer were reported at $273. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Asha Iyer Neurological Surgery median Middle half National median
2019 $331 $582 $138–$3,006 $163
2020 $1,125 $294 $76–$2,174 $114
2021 $391 $387 $105–$2,432 $132
2022 $546 $542 $139–$2,989 $149
2023 $334 $534 $145–$2,697 $160
2024 $5,418 $574 $155–$3,046 $164
2025 $273 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alphatec Spine, Inc $5,193 45 payments
  2. DePuy Synthes Sales Inc. $1,033 17 payments
  3. Medtronic, Inc. $545 10 payments
  4. NuVasive, Inc. $344 4 payments
  5. Abbott Laboratories $177 6 payments
  6. Nevro Corp. $162 3 payments
  7. Stryker Corporation $145 3 payments
  8. Zimvie Inc. $108 4 payments
  9. OssDsign Incorporated $99 1 payment
  10. Globus Medical, Inc. $87 2 payments
  11. Other $528 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,657 104 payments
  2. Travel and Lodging $3,762 10 payments
Products named General payments · program years 2019–2025
  1. Other - Miscellaneous $3,517 13 payments
  2. Invictus MIS $542 11 payments
  3. VIPER $340 5 payments
  4. INFINITY OCCIPITOCERVICAL UPPER THORACIC SYSTEM $247 2 payments
  5. XLIF $228 1 payment
  6. MAZOR X SYSTEM $222 6 payments
  7. SYNFIX $210 2 payments
  8. EXPEDIUM $187 3 payments
  9. Omnia $162 3 payments
  10. Spine & Trauma 3D Navigation $162 3 payments
  11. Other $2,817 67 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

87

Median for Neurosurgery: 83

Drug cost

$522

Median for Neurosurgery: $872

Branded share of claims

0%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 28 $218
Cyclobenzaprine Hcl Generic 36 $160
Tizanidine Hcl Generic 23 $144

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 31 billing codes

Paid by Medicare

$37,435

Medicare's payments for the services billed

Medicare patients

75

Average age 73

Services billed

156

42 women, 33 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 49%
Ischemic heart disease 47%
Chronic kidney disease 35%
COPD 31%
Depression 29%
Heart failure 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

114 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record